Matches in SemOpenAlex for { <https://semopenalex.org/work/W2343187063> ?p ?o ?g. }
- W2343187063 endingPage "916" @default.
- W2343187063 startingPage "901" @default.
- W2343187063 abstract "Introduction: The main pillars for the treatment of chronic kidney disease (CKD) associated anemia are peptidic erythropoiesis stimulating agents (ESAs) and iron preparations. Both approaches benefit from long-term efficacy and safety data but are surrounded by clinical and economic concerns, driving the search for novel anti-anemic drugs.Areas covered: By answering pivotal questions, the authors describe the recent developments of next generation ESAs, introduce cutting-edge iron formulations and focus on investigational approaches that interact with pathways involved in erythropoietin (Epo) synthesis and myeloid hematopoiesis. Finally, the challenges encountered with these drug candidates are discussed.Expert opinion: Current peptidic ESAs are effective and well-tolerated, but are costly, require parenteral application and iron supplementation. ESA resistance may develop calling for increased doses. Therefore, orally available hypoxia-inducible factor (HIF) stabilizing compounds are attractive alternatives, which may be approved in the near future. Prominent compounds are molidustat, daprodustat and roxadustat. HIF stabilizers suppress hepcidin production and improve iron balance as the present ESAs, but also raise safety concerns in association with their pleiotropic actions. Other investigational erythropoietic biologics are growth-differentiation factor-11 (GDF11) ligand traps (sotatercept, luspatercept), which are also well advanced in development. Possibly, they will provide an add-on for established therapies. However, immunogenicity of these compounds still needs to be carefully investigated." @default.
- W2343187063 created "2016-06-24" @default.
- W2343187063 creator A5005625193 @default.
- W2343187063 creator A5046173104 @default.
- W2343187063 date "2016-05-21" @default.
- W2343187063 modified "2023-10-09" @default.
- W2343187063 title "Investigational therapies for renal disease-induced anemia" @default.
- W2343187063 cites W1502294318 @default.
- W2343187063 cites W1507279927 @default.
- W2343187063 cites W1521138540 @default.
- W2343187063 cites W1536433213 @default.
- W2343187063 cites W1560264875 @default.
- W2343187063 cites W1571358690 @default.
- W2343187063 cites W1805394574 @default.
- W2343187063 cites W1822382487 @default.
- W2343187063 cites W1836492536 @default.
- W2343187063 cites W1893364029 @default.
- W2343187063 cites W1912438198 @default.
- W2343187063 cites W1929230157 @default.
- W2343187063 cites W1933582186 @default.
- W2343187063 cites W1964916669 @default.
- W2343187063 cites W1965845267 @default.
- W2343187063 cites W1966021795 @default.
- W2343187063 cites W1968140809 @default.
- W2343187063 cites W1972140920 @default.
- W2343187063 cites W1973935242 @default.
- W2343187063 cites W1974558598 @default.
- W2343187063 cites W1974845135 @default.
- W2343187063 cites W1979134200 @default.
- W2343187063 cites W1979482280 @default.
- W2343187063 cites W1980221984 @default.
- W2343187063 cites W1985500960 @default.
- W2343187063 cites W1985561526 @default.
- W2343187063 cites W1986436077 @default.
- W2343187063 cites W1987326742 @default.
- W2343187063 cites W1987460376 @default.
- W2343187063 cites W1991304993 @default.
- W2343187063 cites W1991852898 @default.
- W2343187063 cites W1993107727 @default.
- W2343187063 cites W1993300336 @default.
- W2343187063 cites W1993415721 @default.
- W2343187063 cites W1998943227 @default.
- W2343187063 cites W2000756993 @default.
- W2343187063 cites W2000977869 @default.
- W2343187063 cites W2001033823 @default.
- W2343187063 cites W2001239531 @default.
- W2343187063 cites W2002636442 @default.
- W2343187063 cites W2003625716 @default.
- W2343187063 cites W2006046265 @default.
- W2343187063 cites W2007832561 @default.
- W2343187063 cites W2009988274 @default.
- W2343187063 cites W2010494523 @default.
- W2343187063 cites W2012068458 @default.
- W2343187063 cites W2012461219 @default.
- W2343187063 cites W2012836529 @default.
- W2343187063 cites W2013322454 @default.
- W2343187063 cites W2014865621 @default.
- W2343187063 cites W2016105952 @default.
- W2343187063 cites W2016849042 @default.
- W2343187063 cites W2017419317 @default.
- W2343187063 cites W2017468796 @default.
- W2343187063 cites W2017990475 @default.
- W2343187063 cites W2021439199 @default.
- W2343187063 cites W2021744317 @default.
- W2343187063 cites W2025629542 @default.
- W2343187063 cites W2027268124 @default.
- W2343187063 cites W2034565548 @default.
- W2343187063 cites W2034590185 @default.
- W2343187063 cites W2034825504 @default.
- W2343187063 cites W2035855731 @default.
- W2343187063 cites W2036768307 @default.
- W2343187063 cites W2040029744 @default.
- W2343187063 cites W2046551865 @default.
- W2343187063 cites W2049912996 @default.
- W2343187063 cites W2050833520 @default.
- W2343187063 cites W2050967224 @default.
- W2343187063 cites W2053326729 @default.
- W2343187063 cites W2057554304 @default.
- W2343187063 cites W2059065213 @default.
- W2343187063 cites W2059147394 @default.
- W2343187063 cites W2059416893 @default.
- W2343187063 cites W2064266243 @default.
- W2343187063 cites W2065322100 @default.
- W2343187063 cites W2065585203 @default.
- W2343187063 cites W2066937360 @default.
- W2343187063 cites W2068355995 @default.
- W2343187063 cites W2069163830 @default.
- W2343187063 cites W2069594569 @default.
- W2343187063 cites W2070959471 @default.
- W2343187063 cites W2070982384 @default.
- W2343187063 cites W2074969682 @default.
- W2343187063 cites W2081093385 @default.
- W2343187063 cites W2082300828 @default.
- W2343187063 cites W2083377780 @default.
- W2343187063 cites W2085755944 @default.
- W2343187063 cites W2087377825 @default.
- W2343187063 cites W2087830638 @default.
- W2343187063 cites W2091952666 @default.